Do you want to read an article? Please log in or register.
α4-integrin receptor desaturation and disease activity return after natalizumab cessation
Multiple Sclerosis
Related content
Multiple Sclerosis
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Lancet Neurol.
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D
doi: 10.1016/S1474-4422
RECOMMENDED
Multiple Sclerosis
Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
doi: 10.1177/1352458520912637.
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis
Mult Scler Relat Disord.
Naegelin Y, Rasenack M, Andelova M, Von Felten S, Fischer-Barnicol B, Amann M, Mehling M, Kappos , Sprenger T, Derfuss T
doi: 10.1016/j.msard.2018.07.005.
Multiple Sclerosis
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
Ann Neurol.
Wolinsky JS, Montalban X, Hauser SL, Giovannoni G, Vermersch P, Bernasconi C, Deol-Bhullar G, Garren H, Chin P, Belachew S, Kappos L
doi: 10.1002/ana.25313.
Aging and Cognitive FunctionsEpilepsy
Epileptic activity in Alzheimer's disease: causes and clinical relevance
Lancet Neurol.
Vossel KA, Tartaglia MC, Nygaard HB, Zeman AZ, Miller BL
doi: 10.1016/S1474-4422
Aging and Cognitive FunctionsAlzheimer’s Disease
Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease
JAMA Neurol.
Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju YS
doi: 10.1001/
Multiple Sclerosis
The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study
Pediatr Neurol.
Alroughani R, Ahmed SF, Behbehani R, Al-Hashel J
doi: 10.1016/
Aging and Cognitive FunctionsEpilepsy
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease
Ann Neurol.
Vossel KA, Ranasinghe KG, Beagle AJ, Mizuiri D, Honma SM, Dowling AF, Darwish SM, Van Berlo V, Barnes DE, Mantle M, Karydas AM, Coppola G, Roberson ED, Miller BL, Garcia PA, Kirsch HE, Mucke L, Nagarajan SS
doi: 10.1002/ana.24794.
Multiple Sclerosis
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
Eur J Neurol.
Havrdova E, Giovannoni G, Gold R, Fox RJ, Kappos L, Phillips JT, Okwuokenye M, Marantz JL
doi: 10.1111/ene.13272.